SOPHARMA AD: NOTIFICATION

opublikowano: 2013-11-14 14:37

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_143__Hidroizomat_above_10%.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 143 / 2013
Date of issue: 2013-11-14
Short name of the issuer
SOPHARMA AD
Subject
NOTIFICATION
Official market - legal basis
Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych
Unofficial market - legal basis
Contents of the report:
Sopharma AD (the “Company") announces that on 13 November 2013 the Company bought 1 000 shares
from the capital of Hidroizpmat AD. After this transaction, the share of Sopharma AD in the capital of Hidroizpmat AD increased to 10.02%.
Annexes
File Description
Current report 143 Hidroizomat above 10%.docCurrent report 143 Hidroizomat above 10%.doc Current report 143 Hidroizomat above 10%

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2013-11-14 Ognian Donev Executive Director